n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and pyrrolidonecarboxylic acid

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with pyrrolidonecarboxylic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, YC; Chou, MY; Tsai, CH1
Hirate, K; Irifune, M; Ishida, T; Nakamura, N; Nishikawa, T; Sato, T; Tanaka, K1

Other Studies

2 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and pyrrolidonecarboxylic acid

ArticleYear
The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2003, Volume: 32, Issue:3

    Topics: Arecoline; Aspirin; Buthionine Sulfoximine; Cell Culture Techniques; Cholinergic Agonists; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Epithelial Cells; Fibroblasts; Glutathione; Humans; Immunohistochemistry; Isoenzymes; Matched-Pair Analysis; Membrane Proteins; Mouth Mucosa; Nitrobenzenes; Oral Submucous Fibrosis; Peroxidases; Prostaglandin-Endoperoxide Synthases; Pyrrolidonecarboxylic Acid; Sulfonamides; Thiazoles; Thiazolidines; Transcription, Genetic; Up-Regulation

2003
Inhibitory effect of cyclooxygenase inhibitors on the step-through passive avoidance performance in mice treated with NC-1900, an arginine-vasopressin fragment analog.
    Methods and findings in experimental and clinical pharmacology, 2007, Volume: 29, Issue:5

    Topics: Animals; Arginine Vasopressin; Avoidance Learning; Behavior, Animal; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Indomethacin; Male; Memory; Mice; Mice, Inbred Strains; Nitrobenzenes; Oligopeptides; Piroxicam; Pyrrolidonecarboxylic Acid; Sulfonamides

2007